What is B. Riley’s Forecast for RIGL Q1 Earnings?
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at B. Riley issued their Q1 2025 EPS estimates for shares of Rigel Pharmaceuticals in a research note issued on Tuesday, March 4th. B. Riley analyst K. Patel expects that the biotechnology company will earn $0.10 per share for the quarter. B. Riley currently […]
